{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:58:58Z","timestamp":1792025938243,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lithuanian Research Council","award":["S-SEN-20-6"],"award-info":[{"award-number":["S-SEN-20-6"]}]},{"name":"Lithuanian Research Council","award":["S-SEN-20-6"],"award-info":[{"award-number":["S-SEN-20-6"]}]},{"DOI":"10.13039\/501100014180","name":"Regional Government of Castilla y Le\u00f3n","doi-asserted-by":"crossref","award":["CLU 2017-09"],"award-info":[{"award-number":["CLU 2017-09"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In this study we have developed a method based on Flux Balance Analysis to identify human metabolic enzymes which can be targeted for therapeutic intervention against COVID-19. A literature search was carried out in order to identify suitable inhibitors of these enzymes, which were confirmed by docking calculations. In total, 10 targets and 12 bioactive molecules have been predicted. Among the most promising molecules we identified Triacsin C, which inhibits ACSL3, and which has been shown to be very effective against different viruses, including positive-sense single-stranded RNA viruses. Similarly, we also identified the drug Celgosivir, which has been successfully tested in cells infected with different types of viruses such as Dengue, Zika, Hepatitis C and Influenza. Finally, other drugs targeting enzymes of lipid metabolism, carbohydrate metabolism or protein palmitoylation (such as Propylthiouracil, 2-Bromopalmitate, Lipofermata, Tunicamycin, Benzyl Isothiocyanate, Tipifarnib and Lonafarnib) are also proposed.<\/jats:p>","DOI":"10.1038\/s41598-021-91526-3","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T10:06:06Z","timestamp":1623060366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A metabolic modeling approach reveals promising therapeutic targets and antiviral drugs to combat COVID-19"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-5557","authenticated-orcid":false,"given":"Fernando","family":"Santos-Beneit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytautas","family":"Ra\u0161kevi\u010dius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytenis A.","family":"Skeberdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-6478","authenticated-orcid":false,"given":"Sergio","family":"Bordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"key":"91526_CR1","first-page":"4016","volume":"24","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C., Sharma, A. R., Sharma, G., Bhattacharya, M. & Lee, S. S. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): Diagnostic and proposed therapeutic options. Eur. Rev. Med. Pharmacol. Sci. 24, 4016\u20134026 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"91526_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.arcmed.2020.05.021","volume":"51","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C. et al. Extensive partnership, collaboration, and teamwork is required to stop the COVID-19 outbreak. Arch. Med. Res. 51, 728\u2013730 (2020).","journal-title":"Arch. Med. Res."},{"key":"91526_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12272-020-01301-7","volume":"44","author":"C Lee","year":"2021","unstructured":"Lee, C. & Choi, W. J. Overview of COVID-19 infammatory pathogenesis from the therapeutic perspective. Arch. Pharm. Res. 44, 99\u2013116 (2021).","journal-title":"Arch. Pharm. Res."},{"key":"91526_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.arcmed.2020.05.001","volume":"51","author":"A Saha","year":"2020","unstructured":"Saha, A. et al. Probable molecular mechanism of remdesivir for the treatment of COVID-19: Need to know more. Arch. Med. Res. 51, 585\u2013586 (2020).","journal-title":"Arch. Med. Res."},{"key":"91526_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.tim.2015.08.007","volume":"23","author":"CM Goodwin","year":"2015","unstructured":"Goodwin, C. M., Xu, S. & Munger, J. Stealing the keys of the kitchen: Viral manipulation of the host cell metabolic network. Trends Microbiol. 23, 789\u2013798 (2015).","journal-title":"Trends Microbiol."},{"key":"91526_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.35772\/ghm.2019.01021","volume":"1","author":"T Nishijima","year":"2019","unstructured":"Nishijima, T., Gatanaga, H. & Oka, S. Tenofovir nephrotoxicity among Asians living with HIV: Review of the literature. Glob. Health Med. 1, 88\u201394 (2019).","journal-title":"Glob. Health Med."},{"key":"91526_CR7","doi-asserted-by":"publisher","first-page":"e22650","DOI":"10.1097\/MD.0000000000022650","volume":"99","author":"A Miyasaka","year":"2020","unstructured":"Miyasaka, A. et al. Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review. Medicine (Baltimore) 99, e22650 (2020).","journal-title":"Medicine (Baltimore)"},{"key":"91526_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jmv.25798","volume":"92","author":"JS Khalili","year":"2020","unstructured":"Khalili, J. S., Zhu, H., Mak, N. S. A., Yan, Y. & Zhu, Y. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. J. Med. Virol. 92, 740\u2013746 (2020).","journal-title":"J. Med. Virol."},{"key":"91526_CR9","doi-asserted-by":"publisher","first-page":"e1004021","DOI":"10.1371\/journal.ppat.1004021","volume":"10","author":"MD Greseth","year":"2014","unstructured":"Greseth, M. D. & Traktman, P. . De. novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog. 10, e1004021 (2014).","journal-title":"PLoS Pathog."},{"key":"91526_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.virol.2014.04.027","volume":"458\u2013459","author":"MC Hagemeijer","year":"2014","unstructured":"Hagemeijer, M. C. et al. Membrane rearrangements mediated by coronavirus nonstructural proteins 3 and 4. Virology 458\u2013459, 125\u2013135 (2014).","journal-title":"Virology"},{"key":"91526_CR11","first-page":"2020.03.22.0023","volume":"22","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2-human protein\u2013protein interaction map reveals drug targets and potential drug-repurposing. Nature 22, 2020.03.22.002386 (2020).","journal-title":"Nature"},{"key":"91526_CR12","doi-asserted-by":"publisher","first-page":"e0190636","DOI":"10.1371\/journal.pone.0190636","volume":"13","author":"V Ra\u0161kevi\u010dius","year":"2018","unstructured":"Ra\u0161kevi\u010dius, V. et al. Genome scale metabolic models as tools for drug design and personalized medicine. PLoS ONE 13, e0190636 (2018).","journal-title":"PLoS ONE"},{"key":"91526_CR13","doi-asserted-by":"publisher","first-page":"19716","DOI":"10.18632\/oncotarget.24805","volume":"9","author":"S Bordel","year":"2018","unstructured":"Bordel, S. Constraint based modeling of metabolism allows finding metabolic cancer hallmarks and identifying personalized therapeutic windows. Oncotarget 9, 19716\u201319729 (2018).","journal-title":"Oncotarget"},{"key":"91526_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2019.12.001","volume":"180","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARSCoV-2 Spike glycoprotein. Cell 180, 1\u201312 (2020).","journal-title":"Cell"},{"key":"91526_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2011","unstructured":"Neuman, B. W. et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 174, 11\u201322 (2011).","journal-title":"J. Struct. Biol."},{"key":"91526_CR16","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/ijms20092167","volume":"20","author":"D Casares","year":"2019","unstructured":"Casares, D., Escriba, P. V. & Rossello, C. A. Membrane lipid composition: Effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues. Int. J. Mol. Sci. 20, 2167 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"91526_CR17","doi-asserted-by":"publisher","first-page":"e02325","DOI":"10.1128\/mBio.02325-17","volume":"9","author":"C Casta\u00f1o-Rodriguez","year":"2018","unstructured":"Casta\u00f1o-Rodriguez, C. et al. Role of severe acute respiratory syndrome Coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. mBio 9, e02325-17 (2018).","journal-title":"mBio"},{"key":"91526_CR18","doi-asserted-by":"publisher","first-page":"e1000906","DOI":"10.1371\/journal.pcbi.1000906","volume":"6","author":"RJ De Boer","year":"2010","unstructured":"De Boer, R. J., Ribeiro, R. M. & Perelson, A. S. Current estimates for HIV-1 production imply rapid viral clearance in lymphoid tissues. PLoS Comput. Biol. 6, e1000906 (2010).","journal-title":"PLoS Comput. Biol."},{"key":"91526_CR19","doi-asserted-by":"publisher","first-page":"i813","DOI":"10.1093\/bioinformatics\/btaa813","volume":"36","author":"A Renz","year":"2020","unstructured":"Renz, A., Widerspick, L. & Dr\u00e4ger, A. FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2. Bioinformatics 36, i813\u2013i821 (2020).","journal-title":"Bioinformatics"},{"key":"91526_CR20","doi-asserted-by":"publisher","first-page":"20180125","DOI":"10.1098\/rsif.2018.0125","volume":"15","author":"S Aller","year":"2018","unstructured":"Aller, S., Scott, A., Sarkar-Tyson, M. & Soyer, O. S. Integrated human-virus metabolic stoichiometric modelling predicts host-based antiviral targets against Chikungunya, Dengue and Zika viruses. J. R. Soc. Interface 15, 20180125 (2018).","journal-title":"J. R. Soc. Interface"},{"key":"91526_CR21","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.7314\/APJCP.2013.14.4.2607","volume":"14","author":"Y Zhu","year":"2013","unstructured":"Zhu, Y., Zhuang, J.-X., Wang, Q., Zhang, H.-Y. & Yang, P. Inhibitory effect of benzyl isothiocyanate on proliferation in vitro of human glioma cells. Asian Pac. J. Cancer Prev. 14, 2607\u20132610 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"91526_CR22","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1021\/acschembio.5b00466","volume":"10","author":"V Piano","year":"2015","unstructured":"Piano, V. et al. Discovery of inhibitors for the ether lipid-generating enzyme AGPS as anti-cancer agents. ACS Chem. Biol. 10, 2589\u20132597 (2015).","journal-title":"ACS Chem. Biol."},{"key":"91526_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jmb.2005.05.053","volume":"351","author":"LS Huang","year":"2005","unstructured":"Huang, L. S., Cobessi, D., Tung, E. Y. & Berry, E. A. Binding of the respiratory chain inhibitor antimycin to the mitochondrial bc1 complex: A new crystal structure reveals an altered intramolecular hydrogen-bonding pattern. J. Mol. Biol. 351, 573\u2013597 (2005).","journal-title":"J. Mol. Biol."},{"key":"91526_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1006\/bbrc.1999.0510","volume":"257","author":"SJ Steinberg","year":"1999","unstructured":"Steinberg, S. J., Wang, S. J., Kim, D. G., Mihalik, S. J. & Watkins, P. A. Human very-long-chain acyl-CoA synthetase: Cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 257, 615\u2013621 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"91526_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia, F. et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature 569, 73\u201378 (2019).","journal-title":"Nature"},{"key":"91526_CR26","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1194\/jlr.M700050-JLR200","volume":"48","author":"Y Fujimoto","year":"2007","unstructured":"Fujimoto, Y. et al. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J. Lipid Res. 48, 1280\u20131292 (2007).","journal-title":"J. Lipid Res."},{"key":"91526_CR27","doi-asserted-by":"publisher","first-page":"e1003401","DOI":"10.1371\/journal.ppat.1003401","volume":"9","author":"JA Nchoutmboube","year":"2013","unstructured":"Nchoutmboube, J. A. et al. Increased long chain acyl-Coa synthetase activity and fatty acid import is linked to membrane synthesis for development of picornavirus replication organelles. PLoS Pathog. 9, e1003401 (2013).","journal-title":"PLoS Pathog."},{"key":"91526_CR28","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1016\/S0021-9258(20)64309-5","volume":"266","author":"H Tomoda","year":"1991","unstructured":"Tomoda, H., Igarashi, K., Cyong, J. C. & Omura, S. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation. J. Biol. Chem. 266, 4214\u20134219 (1991).","journal-title":"J. Biol. Chem."},{"key":"91526_CR29","doi-asserted-by":"publisher","first-page":"21276","DOI":"10.1074\/jbc.M114.582999","volume":"289","author":"JM Liefhebber","year":"2014","unstructured":"Liefhebber, J. M., Hague, C. V., Zhang, Q., Wakelam, M. J. & McLauchlan, J. Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus. J. Biol. Chem. 289, 21276\u201321288 (2014).","journal-title":"J. Biol. Chem."},{"key":"91526_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejmech.2012.02.010","volume":"50","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. Novel triacsin C analogs as potential antivirals against rotavirus infections. Eur. J. Med. Chem. 50, 311\u2013318 (2012).","journal-title":"Eur. J. Med. Chem."},{"key":"91526_CR31","doi-asserted-by":"publisher","first-page":"e1003333","DOI":"10.1371\/journal.ppat.1003333","volume":"9","author":"E Koyuncu","year":"2013","unstructured":"Koyuncu, E., Purdy, J. G., Rabinowitz, J. D. & Shenk, T. Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny. PLoS Pathog. 9, e1003333 (2013).","journal-title":"PLoS Pathog."},{"key":"91526_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.108.193011","volume":"105","author":"RR Singaraja","year":"2009","unstructured":"Singaraja, R. R. et al. Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. Circ. Res. 105, 138\u2013147 (2009).","journal-title":"Circ. Res."},{"key":"91526_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1194\/jlr.M800270-JLR200","volume":"50","author":"BC Jennings","year":"2009","unstructured":"Jennings, B. C. et al. 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro. J. Lipid Res. 50, 233\u2013242 (2009).","journal-title":"J. Lipid Res."},{"key":"91526_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-5793(86)81082-1","volume":"209","author":"E Lee","year":"1986","unstructured":"Lee, E. & Kariya, K. Propylthiouracil, a selective inhibitor of NADH-cytochrome b5 reductase. FEBS Lett. 209, 49\u201351 (1986).","journal-title":"FEBS Lett."},{"key":"91526_CR35","unstructured":"Propylthiouracil. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. 2012\u2013Bookshelf ID: NBK547973 (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2020)."},{"key":"91526_CR36","unstructured":"Antithyroid Agents. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. 2012\u2013Bookshelf ID: NBK548603 (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2014)."},{"key":"91526_CR37","doi-asserted-by":"publisher","first-page":"16861","DOI":"10.1074\/jbc.M114.629964","volume":"290","author":"M Rahaman","year":"2015","unstructured":"Rahaman, M. et al. Structure guided chemical modifications of Propylthiouracil reveal novel small molecule inhibitors of cytochrome b5 Reductase 3 that increase nitric oxide bioavailability. J. Biol. Chem. 290, 16861\u201316872 (2015).","journal-title":"J. Biol. Chem."},{"key":"91526_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","volume":"92","author":"APS Rathore","year":"2011","unstructured":"Rathore, A. P. S. et al. Celgosivir treatment misfolds Dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. Antivir. Res. 92, 453\u2013460 (2011).","journal-title":"Antivir. Res."},{"key":"91526_CR39","doi-asserted-by":"publisher","first-page":"e0004851","DOI":"10.1371\/journal.pntd.0004851","volume":"10","author":"C Sung","year":"2016","unstructured":"Sung, C. et al. Extended evaluation of virological, immunological and pharmacokinetic endpoints of CELADEN: A randomized, placebo-controlled trial of Celgosivir in Dengue fever patients. PLoS Negl. Trop. Dis. 10, e0004851 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"91526_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fmicb.2020.00531","volume":"11","author":"G Bhushan","year":"2020","unstructured":"Bhushan, G. et al. Iminosugars with endoplasmic reticulum \u03b1-glucosidase inhibitor activity inhibit ZIKV replication and reverse cytopathogenicity in vitro. Front. Microbiol. 11, 531 (2020).","journal-title":"Front. Microbiol."},{"key":"91526_CR41","first-page":"860","volume":"10","author":"D Durantel","year":"2009","unstructured":"Durantel, D. Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection. Curr. Opin Investig. Drugs 10, 860\u2013870 (2009).","journal-title":"Curr. Opin Investig. Drugs"},{"key":"91526_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ja.2007.62","volume":"60","author":"NPJ Price","year":"2007","unstructured":"Price, N. P. J. & Tsvetanova, B. Biosynthesis of the tunicamycins: A review. J. Antibiot. (Tokyo) 60, 485\u2013491 (2007).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"91526_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/jvi.57.1.117-123.1986","volume":"57","author":"LM Hutt-Fletcher","year":"1986","unstructured":"Hutt-Fletcher, L. M., Balachandran, N. & LeBlanc, P. A. Modification of Epstein\u2013Barr virus replication by tunicamycin. J. Virol. 57, 117\u2013123 (1986).","journal-title":"J. Virol."},{"key":"91526_CR44","doi-asserted-by":"publisher","first-page":"104586","DOI":"10.1016\/j.micpath.2020.104586","volume":"149","author":"AA Dawood","year":"2020","unstructured":"Dawood, A. A. & Altobje, M. A. Inhibition of N-linked glycosylation by Tunicamycin may contribute to the treatment of SARS-CoV-2. Microb. Pathog. 149, 104586 (2020).","journal-title":"Microb. Pathog."},{"key":"91526_CR45","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s004180050256","volume":"109","author":"A Dinter","year":"1998","unstructured":"Dinter, A. & Berger, E. G. Golgi-disturbing agents. Histochem. Cell Biol. 109, 571\u2013590 (1998).","journal-title":"Histochem. Cell Biol."},{"key":"91526_CR46","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/jmv.26078","volume":"92","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C. et al. COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J. Med. Virol. 92, 2260\u20132262 (2020).","journal-title":"J. Med. Virol."},{"key":"91526_CR47","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.arcmed.2020.05.009","volume":"51","author":"A Saha","year":"2020","unstructured":"Saha, A. et al. Tocilizumab: A therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch. Med. Res. 51, 595\u2013597 (2020).","journal-title":"Arch. Med. Res."},{"key":"91526_CR48","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/jmv.25997","volume":"92","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty, C. et al. Consider TLR5 for new therapeutic development against COVID-19. J. Med. Virol. 92, 2314\u20132315 (2020).","journal-title":"J. Med. Virol."},{"key":"91526_CR49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jmv.25736","volume":"92","author":"M Bhattacharyia","year":"2020","unstructured":"Bhattacharyia, M. et al. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J. Med. Virol. 92, 618\u2013631 (2020).","journal-title":"J. Med. Virol."},{"key":"91526_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S1473-3099(20)30911-7","volume":"21","author":"B Young","year":"2021","unstructured":"Young, B., Tan, T. T. & Leo, Y. S. The place for remdesivir in COVID-19 treatment. Lancet Infect. Dis. 21, 20\u201321 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"91526_CR51","doi-asserted-by":"publisher","first-page":"585899","DOI":"10.3389\/fmolb.2020.585899","volume":"7","author":"TA Sumon","year":"2021","unstructured":"Sumon, T. A. et al. A revisit to the research updates of drugs, vaccines, and bioinformatics approaches in combating COVID-19 pandemic. Front. Mol. Biosci. 7, 585899 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"91526_CR52","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1021\/acs.jproteome.0c00327","volume":"19","author":"RO Barros","year":"2020","unstructured":"Barros, R. O., Junior, F. L. C. C., Pereira, W. S., Oliveira, N. M. N. & Ramos, R. Interaction of drugs candidates with various SARS-CoV-2 receptors: An in silico study to combat COVID-19. J. Proteome Res. 19, 4567\u20134575 (2020).","journal-title":"J. Proteome Res."},{"key":"91526_CR53","first-page":"103848","volume":"122","author":"O Kadioglu","year":"2020","unstructured":"Kadioglu, O., Saeed, M., Johannes Greten, H. & Efferth, T. Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Bull. World Health Organ. 122, 103848 (2020).","journal-title":"Bull. World Health Organ."},{"key":"91526_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(14)70730-3","volume":"14","author":"JG Low","year":"2014","unstructured":"Low, J. G. et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect. Dis. 14, 706\u2013715 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"91526_CR55","doi-asserted-by":"publisher","first-page":"e03641","DOI":"10.7554\/eLife.03641","volume":"3","author":"K Yizhak","year":"2014","unstructured":"Yizhak, K. et al. Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer. eLife 3, e03641 (2014).","journal-title":"eLife"},{"key":"91526_CR56","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/msb.2013.5","volume":"9","author":"A Mardinoglu","year":"2013","unstructured":"Mardinoglu, A. et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 9, 649 (2013).","journal-title":"Mol. Syst. Biol."},{"key":"91526_CR57","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"91526_CR58","doi-asserted-by":"publisher","first-page":"D343","DOI":"10.1093\/nar\/gkx987","volume":"46","author":"E Wingender","year":"2018","unstructured":"Wingender, E., Schoeps, T., Haubrock, M., Krull, M. & D\u00f6nitz, J. TFClass: Expanding the classification of human transcription factors to their mammalian orthologs. Nucleic Acids Res. 46, D343\u2013D347 (2018).","journal-title":"Nucleic Acids Res."},{"key":"91526_CR59","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"91526_CR60","doi-asserted-by":"publisher","first-page":"W174","DOI":"10.1093\/nar\/gkv342","volume":"43","author":"J Yang","year":"2015","unstructured":"Yang, J. & Zhang, Y. I-TASSER server: New development for protein structure and function predictions. Nucleic Acids Res. 43, W174\u2013W181 (2015).","journal-title":"Nucleic Acids Res."},{"key":"91526_CR61","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","volume":"21","author":"Y Song","year":"2013","unstructured":"Song, Y. et al. High-resolution comparative modeling with RosettaCM. Structure 21, 1735\u20131742 (2013).","journal-title":"Structure"},{"key":"91526_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","volume":"27","author":"P Benkert","year":"2010","unstructured":"Benkert, P., Biasini, M. & Schwede, T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27, 343\u2013350 (2010).","journal-title":"Bioinformatics"},{"key":"91526_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pro.3730","volume":"29","author":"DS Goodsell","year":"2020","unstructured":"Goodsell, D. S. et al. RCSB protein data bank: Enabling biomedical research and drug discovery. Protein Sci. 29, 52\u201365 (2020).","journal-title":"Protein Sci."},{"key":"91526_CR64","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"91526_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O'Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform."},{"key":"91526_CR66","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17460441.2016.1216967","volume":"11","author":"S Kim","year":"2016","unstructured":"Kim, S. Getting the most out of PubChem for virtual screening. Expert Opin. Drug Discov. 11, 843\u2013855 (2016).","journal-title":"Expert Opin. Drug Discov."},{"key":"91526_CR67","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2014ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"91526_CR68","doi-asserted-by":"publisher","first-page":"15451","DOI":"10.1038\/s41598-017-15571-7","volume":"7","author":"NM Hassan","year":"2017","unstructured":"Hassan, N. M., Alhossary, A. A., Mu, Y. & Mwoh, C. K. Protein-ligand blind docking using QuickVina-W with inter-process spatio-temporal integration. Sci. Rep. 7, 15451 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91526-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91526-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T10:08:33Z","timestamp":1675418913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91526-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["91526"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-91526-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"12 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11982"}}